CompletedPhase 4NCT00904202

A Study Of Lidocaine Patch 5% Alone, Gabapentin Alone, And Lidocaine Patch 5% And Gabapentin In Combination For The Relief Of Pain In Patients With Diverse Peripheral Neuropathic Pain Conditions

Studying Complex regional pain syndrome type 1

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Endo Pharmaceuticals
Principal Investigator
Sr Director
Endo Pharmaceuticals
Intervention
Placebo Capsules + Placebo Patch(drug)
Enrollment
62 enrolled
Eligibility
18 years · All sexes
Timeline
2003

Study locations (7)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00904202 on ClinicalTrials.gov

Other trials for Complex regional pain syndrome type 1

Additional recruiting or active studies for the same condition.

See all trials for Complex regional pain syndrome type 1

← Back to all trials